Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2331061 Target Snapshot

Serine/threonine-protein kinase B-raf · SINGLE PROTEIN · Mus musculus

84Compounds
11Assays
4Approved Drugs
80.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-12

Protein identity stays anchored to UniProt P28028. Use UniProt P28028 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P28028 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-12
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Serine/threonine-protein kinase B-raf as ChEMBL target CHEMBL2331061, mapped to UniProt P28028. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Serine/threonine-protein kinase B-raf
SINGLE PROTEIN · Mus musculus
As of 2026-09-12
ChEMBL target ID
CHEMBL2331061
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-12
www.ebi.ac.uk
UniProt accession
P28028
Serine/threonine-protein kinase B-raf
UniProt accession via ChEMBL component mapping As of 2026-09-12
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-12
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Serine/threonine-protein kinase B-raf is the right protein anchor across sources, using UniProt P28028 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSerine/threonine-protein kinase B-raf
UniProt AccessionP28028
Component TypeProtein
Sequence Length751 aa

Serine/threonine-protein kinase B-raf

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Serine/threonine-protein kinase B-raf, mapped to UniProt P28028. Sequence length is 751 aa.

Mapped IDP28028
Review nameSerine/threonine-protein kinase B-raf
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

4
Approved
Assay Mix

Activity Type Distribution

IC5080.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4294787 8.0 IC50 10.0 Preclinical
CHEMBL1229517 7.52 IC50 30.0 Approved
CHEMBL1079742 7.4 IC50 40.0 Approved
CHEMBL4209555 7.4 IC50 40.0 Preclinical
CHEMBL4290513 7.3 IC50 50.0 Preclinical
CHEMBL553 7.22 IC50 60.0 Approved
CHEMBL4277125 7.22 IC50 60.0 Preclinical
CHEMBL4206547 7.0 IC50 100.0 Preclinical
CHEMBL4208224 7.0 IC50 100.0 Preclinical
CHEMBL1336 6.89 IC50 130.0 Approved
Distribution

pChEMBL Value Distribution

18
5.0
19
5.5
20
6.0
3
6.5
7
7.0
1
7.5
1
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

VEMURAFENIB
CHEMBL1229517
Approved 2011
SORAFENIB
CHEMBL1336
Approved 2005
ERLOTINIB HYDROCHLORIDE
CHEMBL1079742
Approved 2004
ERLOTINIB
CHEMBL553
Approved 2004
Assay Landscape

Assay Landscape

11
Total Assays
78
Tested Compounds
1
Assay Types
Binding — 11 assays, 78 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 10 78 5.9
cell-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine